Stocks · News reference

Morgan Stanley Maintains Equal-Weight on Incyte, Raises Price Target to $104

Jul 23, 2026, 6:02 PMBenzinga Newsdesk

Morgan Stanley analyst Judah Frommer maintains Incyte (NASDAQ:INCY) with a Equal-Weight and raises the price target from $103 to $104.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 20, 2026, 7:44 PMBenzinga Newsdesk
Canaccord Genuity Initiates Coverage On Incyte with Buy Rating, Announces Price Target of $152
Canaccord Genuity analyst John Newman initiates coverage on Incyte (NASDAQ:INCY) with a Buy rating and announces Price Target of $152.
Read original at benzinga
INCY
BenzingaAug 20, 2026, 11:41 AMBenzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $150 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Incyte (NASDAQ:INCY) with a Buy and maintains $150 price target.
Read original at benzinga
INCY
BenzingaAug 17, 2026, 7:19 PMBenzinga Newsdesk
Incyte shares are trading higher after Piper Sandler maintained its Overweight rating on the stock and raised its price target from $110 to $130.
Read original at benzinga
INCY
BenzingaAug 17, 2026, 4:11 PMBenzinga Newsdesk
Piper Sandler Maintains Overweight on Incyte, Raises Price Target to $130
Piper Sandler analyst Allison Bratzel maintains Incyte (NASDAQ:INCY) with a Overweight and raises the price target from $110 to $130.
Read original at benzinga
INCY